Unknown

Dataset Information

0

METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression

ABSTRACT:

SUBMITTER: Li J 

PROVIDER: S-EPMC12374814 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.
| S-EPMC10280857 | biostudies-literature
Unknown CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A.
| S-EPMC12719574 | biostudies-literature
Unknown DRP1 Promotes BRAF<sup>V600E</sup>-Driven Tumor Progression and Metabolic Reprogramming in Colorectal Cancer.
| S-EPMC7961078 | biostudies-literature
Unknown HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis.
| S-EPMC11372083 | biostudies-literature
Unknown OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma.
| S-EPMC12323000 | biostudies-literature
Unknown PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming.
| S-EPMC7010223 | biostudies-literature
Unknown xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.
| S-EPMC6127081 | biostudies-literature
Unknown EPDR1 promotes gastric cancer progression via STAT3-mediated fatty acid metabolic reprogramming.
| S-EPMC12797778 | biostudies-literature
Unknown Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer.
| S-EPMC11840119 | biostudies-literature
Unknown Regulatory role of phosphatidylcholine metabolic reprogramming in colorectal cancer progression and neutrophil interactions.
| S-EPMC12721150 | biostudies-literature